Do science and money go together? The case of the French biotech industryRodolphe Durand · Olga Bruyaka · Vincent MangematinDiscuss this article →December 2008pp. 1281-1299DOI: 10.1002/smj.707 ↗
Does it pay to be different? An analysis of the relationship between corporate social and financial performanceStephen Brammer · Andrew MillingtonDiscuss this article →December 2008pp. 1325-1343DOI: 10.1002/smj.714 ↗
Outside directors' industry‐specific experience and firms' liability of newnessYasemin Y. Kor · Vilmos F. MisangyiDiscuss this article →December 2008pp. 1345-1355DOI: 10.1002/smj.709 ↗
Relevance of organizational capabilities and its dynamics: what to learn from entrants' product portfolios about the determinants of entry timingGwendolyn K. LeeDiscuss this article →December 2008pp. 1257-1280DOI: 10.1002/smj.716 ↗
The effect of CEOs on firm performanceAlison MackeyDiscuss this article →December 2008pp. 1357-1367DOI: 10.1002/smj.708 ↗
Top management incentive compensation and knowledge sharing in multinational corporationsCarl F. Fey · Patrick FuruDiscuss this article →December 2008pp. 1301-1323DOI: 10.1002/smj.712 ↗
